78 research outputs found

    ํ•œ๊ตญ์ธ ์‚ฌ๋ง๊ณผ ๊ด€๋ จ๋œ ๊ฑด๊ฐ• ํ–‰ํƒœ์š”์ธ์˜ ๋ณตํ•ฉ์œ„ํ—˜๋„์— ๊ด€ํ•œ ์ฝ”ํ˜ธํŠธ ์—ฐ๊ตฌ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์˜ํ•™๊ณผ ์˜ˆ๋ฐฉ์˜ํ•™ ์ „๊ณต, 2013. 2. ์œ ๊ทผ์˜.Objectives Lifestyle factors such as obesity, smoking habit and alcohol drinking habit are known to be associated with increased risk of all-cause mortality in Korea. However, little has examined the association of combined life-style factors with the risk of mortality. Methods The study population of 15,740 participants over 20 years old was selected from the Korean Multi-center Cancer Cohort (KMCC) study. Information on lifestyle factors was obtained through structured questionnaire interview. The total number of persons who completed the follow-up through the Death Certificate database of the National Statistical Office was 145,218.4 person-years by the end of December 31, 2008. The total number of death during the study period was 1,094 persons, and 474 deaths were due to cancer and 229 persons were due to cardio-vascular diseases. Each risk factor was dichotomized based on the previous study as followsbody mass index (BMI) under 22.6 or over 27.5 kg/m2 versus 22.6~27.5 kg/m2current or past smokers versus non-smokersnon-drinkers or drinkers with alcohol amount of 90 gram per week or more versus drinkers less than 90 grams per week. Combined effect of three risk factors was estimated in two different waysaccording to the number of risk factors qualitatively, and to the combined risk scores ranged from 0 to 14 quantitatively. The hazard ratios (HRs) and 95% confidence intervals (CI) for mortality were estimated by Coxs proportional hazard regression model adjusting for age, sex, locality, education, marriage, and the past history of chronic diseases. Results The risk of dying was 1.47 times (95% CI = 1.27~1.69) in BMI, 1.50 times (95% CI=1.25~1.79) in smoking habit, and 1.36 times (95% CI=1.08~1.72) higher in alcohol drinking habit than the baseline hazard. The HRs for cancer death was 1.35 (95% CI=1.10~1.66) in BMI, and 1.75 (95% CI=1.32~2.33) in smoking habit, but not statistically significant in alcohol drinking habit. The HRs for both all-causes mortality and cancer mortality showed linearly increasing pattern with statistical significant according to the number of risk factor (p<0.001). Overall, the combined effect of lifestyle factors was more prominent in female. Particularly noteworthy was that the risk of dying increases according to the combined risk score increasing (p<0.001). Subjects with highest score (1`0~14) had significantly at the greatest risk of deaths (HR=3.46, 95% CI=1.89-6.32). The risk of dying was more prominent in female and participants under age<60. Conclusions This study confirms abnormal BMI, smoking habit and alcohol drinking habit are major risk factor of premature deaths, as well as cancer death in Korea. Combined effect of lifestyle factors would additively be associated with marked increased risks of both all-causes and cancer-specific death in Korea.Abstract โ…ฐ Contents iv List of tables v List of figures viii List of abbreviation ix Introduction 1 Materials and Methods 5 Study population and follow-up for outcomes 5 Measurement of lifestyle factors 7 Classification of risk lifestyle factors 8 Estimation of the combined effect 9 Statistical analysis 11 Results 14 Discussion 20 References 66 Abstract in Korean 71Maste

    Timing of Admission to the Surgical Intensive Care Unit is Associated with in-Hospital Mortality

    Get PDF
    Purpose The relationship between the timing of admission (work-hours or after-hours) to the intensive care unit (ICU) and mortality among surgical ICU (SICU) patients is unclear. This study aimed to investigate whether admission to SICU during after-hours was associated with in-hospital mortality. Methods This retrospective cohort study was conducted in a tertiary academic hospital. The data of 571 patients who were admitted to the SICU and whose complete medical records were available were analyzed. Work-hours were defined as 07:00 to 19:00 Monday to Friday, during which the ICU was staffed with intensivists. After-hours were defined as any other time during which the SICU was not staffed with intensivists. The primary outcome measure was in-hospital mortality according to the time of admission (work-hours or after-hours) to the SICU. Results A total of 333 patients, were admitted to the SICU during work-hours, and 238 patients after-hours. Unplanned admissions (47.1% vs. 33.3%, p < 0.001), acute physiology and chronic health evaluation II score โ‰ฅ 25 (23.9% vs. 11.1%, p < 0.001), the need for ventilator support (34.0% vs. 17.4%, p < 0.001), and the use of vasopressors (50.0% vs. 33.3%, p < 0.001) were significantly higher in the after-hours group compared with the work-hours group. Multivariate analyses revealed that the timing of SICU admission was an independent predictor of in-hospital mortality (odds ratio, 2.526; 95% confidence interval, 1.010-6.320; p = 0.048). Conclusion This study showed that admission to the SICU during after-hours was associated with increased in-hospital mortality.ope

    Isolated Splenic Metastasis from Colorectal Carcinoma

    Get PDF
    Most splenic metastasis occurs in patients with the widespread visceral metastasis. However, isolated splenic metastasis is very rare. Here we report an isolated splenic metastasis in a patient with colon cancer without any other metastasis and a review of the literature are presented. A 57-year female underwent right hemicolectomy for adenocarcinoma of ascending colon on February, 2004 and the stage of carcinoma was T3N2M0. On August 2004, she hospitalized due to isolated splenic metastasis. The serum carcinoembryonic antigen level was 1.69 ng/ml. An abdominal CT scan revealed a 1 cm sized metastatic mass at the hilum of the spleen. The same finding was shown on MRI and PET. There was no other recurrence or metastatic evidence in radiologic study. Splenectomy was performed and pathologic result of the splenic tumor was metastatic adenocarcinoma from colon cancer. After operation, she was treated with adjuvant chemotherapy. It may be necessary to attend the splenic metatasis in patients who underwent curative resection for colorectal cancer even though splenic metastasis is very rare.ope

    Effect of Yogurt Enriched Water-soluble Fiber on Functional Constipation

    Get PDF
    Purpose Although a diet that is rich in fiber is widely recommended to prevent and treat constipation, the efficacy of fiber supplements with yogurt has not been studied sufficiently. The aim of this study was to evaluate the effect of a yogurt enriched water-soluble fiber on the various symptoms of constipation in female adults with functional constipation. Methods We did a double-blind and case-controlled study between two groups (placebo vs. fiber group), which were randomly allocated out of 42 subjects with functional constipation by using Rome II criteria. Bowel habits, daily nutritional intakes and physical activities were determined by using a questionnaire, and the segmental colonic transit time was evaluated three times: before treatment, after 4 weeks of treatment, and at the end of the study (2 weeks after treatment). Results After 4 weeks of treatment, all defecation symptoms tested, except manual evacuation, showed significant improvements in the fiber group; fiber-enriched yogurt increased the number of bowel movements (P=0.002), reduced the presence of hard stools (P=0.001), improved the frequency of straining (P=0.048), the sense of incomplete evacuation (P=0.013), and the sense of anorectal obstruction (P=0.032). The total colonic transit time was shortened after intake of fiber-enriched yogurt (P=0.023). Satisfactory relief was significantly higher in the fiber group (P=0.011). Conclusions Functional constipation may be improved with water-soluble fiber supplements in yogurt without serious side effects.ope

    Prognostic Factors and Survival Rate of Ampulla of Vater Cancer after Curative Surgery

    Get PDF
    Purpose: Ampulla of Vater cancer has a more favorable prognosis than other malignant tumors of the periampullary region, but prognostic factors have not been identified. The aim of this study was to evaluate the prognostic factors of ampulla of Vater cancer from a single hospital experience. Methods: The medical records of the 102 patients with ampulla of Vater cancer which underwent curative surgery between 1992 and 2002, were reviewed. All specimens were critically reviewed by an expert pathologist. The relationships between survival and the clinicopathological variables were assessed. Results: In 120 patients that presented with ampulla of Vater cancer, 102 (85%) were resected. The 5 year survival rate was 69.1%. A univariate analysis showed the survival was closely related to gender, the tumor gross morphology, invasion depth and lymph node metastasis. A multivariate analysis identified two significant factors; the depth of invasion and gender. Twenty nine of the 102 patients suffered a recurrence. Conclusion: The depth of invasion and gender were independent significant prognostic factors of resectable ampulla of Vater cancer. Careful observation is essential for liver metastasis after surgery, especially in patients that have these factors.ope

    ํ•™์Šต๋ถ€์ง„ ์ง„๋‹จ์„ ์œ„ํ•œ ์—ฐ์‚ฐ์œ ์ฐฝ์„ฑ ๊ฒ€์‚ฌ ๊ฐœ๋ฐœ ๋ฐ ํƒ€๋‹นํ™”

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :ํ˜‘๋™๊ณผ์ • ํŠน์ˆ˜๊ต์œก์ „๊ณต,2004.ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)-

    The Representation of Son Gi-yangs Scholarly Lineage : The Album of Sixteen Views around Chiltanjeong

    No full text

    Inhibitory Effect of coptisine on Epithelial-to-Mesenchymal Transition

    No full text
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์•ฝํ•™๊ณผ, 2014. 8. ์ด์ƒ๊ตญ.Epithelial-to-mesenchymal transition (EMT)์€ ์ƒํ”ผ์„ธํฌ (epithelial cell)๊ฐ€ ๊ณ ์œ ์˜ ํŠน์„ฑ๊ณผ cell-cell junction์„ ์žƒ๊ณ  ๊ฐ„์—ฝ์„ธํฌ (mesenchymal cell)์˜ ํ˜•ํƒœ์™€ ์„ฑ์งˆ์„ ํš๋“ํ•˜๋Š” ๊ณผ์ •์œผ๋กœ ์•”์˜ ์นจ์œค, ์ „์ด์˜ ์ค‘์š”ํ•œ ํŠน์ง•์ด๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ์‚ฌ๋žŒ ํ์•” ์„ธํฌ์ฃผ์ธ A549๋ฅผ ์ด์šฉํ•˜์—ฌ ํ™ฉ๋ จ (Coptis japonica)์—์„œ ๋ถ„๋ฆฌ๋œ isoquinoline alkaloid๊ณ„ ๋ฌผ์งˆ์ธ coptisine์˜ EMT ์–ต์ œ ํšจ๋Šฅ์„ ํ™•์ธํ•˜๊ณ  ๊ทธ ์ž‘์šฉ๊ธฐ์ „์„ ์—ฐ๊ตฌํ•˜์˜€๋‹ค. A549์„ธํฌ์— ๋Œ€ํ•œ ์„ธํฌ ์ฆ์‹ ์–ต์ œ ํšจ๋Šฅ์„ ํ‰๊ฐ€ํ•œ ๊ฒฐ๊ณผ, coptisine์— ์˜ํ•ด ์„ธํฌ์˜ ์ฆ์‹์ด ์‹œ๊ฐ„ ๋ฐ ๋†๋„ ์˜์กด์ ์œผ๋กœ ์–ต์ œ๋จ์„ ํ™•์ธํ•˜์˜€๋‹ค (IC5042.7 ฮผM (24h), 15.9 ฮผM (48h), 8.4 ฮผM (72h)). EMT์™€ ๊ด€๋ จํ•œ ์ž‘์šฉ๊ธฐ์ „์„ ์•Œ์•„๋ณธ ๊ฒฐ๊ณผ, coptisine์€ ์•”์˜ ์ง„ํ–‰์„ ์–ต์ œํ•˜๊ณ  ์„ธํฌ๊ฐ„ ์—ฐ๊ฒฐ์„ ์œ ์ง€ํ•˜์—ฌ ์ด๋™์„ฑ์„ ๊ฐ์†Œ์‹œํ‚ค๋Š” E-cadherin์˜ ์œ ์ „์ž์™€ ๋‹จ๋ฐฑ์งˆ์˜ ๋ฐœํ˜„์„ ๋ชจ๋‘ ์ฆ๊ฐ€์‹œ์ผฐ๋‹ค. ๋˜ํ•œ E-cadherin์˜ ๋‚ด์ธ์„ฑ ์–ต์ œ์ œ๋กœ ์ž‘์šฉํ•˜๋Š” Snail์—๋„ ์˜ํ–ฅ์„ ๋ฏธ์ณ ์œ ์ „์ž์™€ ๋‹จ๋ฐฑ์งˆ์˜ ๋ฐœํ˜„์„ ์–ต์ œํ•˜์˜€๋‹ค. ๊ทธ ์™ธ์— EMT์—์„œ ํŠน์ด์ ์œผ๋กœ ๋ณ€ํ™”ํ•˜๋Š” matrix metalloproteinase-2 (MMP-2), vimentin, N-cadherin ๋“ฑ์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ๊ฒƒ์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋˜ํ•œ wound healing assay, colony dispersion assay, invasion assay ๋“ฑ์„ ํ†ตํ•ด coptisine์ด A549 ์„ธํฌ์˜ ์ด๋™์„ฑ, ์นจ์œค์„ฑ์„ ์ €ํ•ดํ•จ์„ ๋ฐํ˜”๋‹ค. ๋”์šฑ ๊ตฌ์ฒด์ ์ธ EMT ์ €ํ•ด ๊ธฐ์ „์„ ์•Œ์•„๋ณด๊ธฐ ์œ„ํ•ด transforming growth factorฮฒ1 (TGFฮฒ1)๋ฅผ ์ฒ˜๋ฆฌํ•œ A549 ์„ธํฌ์—์„œ coptisine์˜ ํšจ๊ณผ๋ฅผ ์‚ดํŽด๋ณธ ๊ฒฐ๊ณผ Extracellular signal-regulated kinases (ERK)1/2, Akt, glycogen synthase kinase3ฮฒ (GSK3ฮฒ) ์˜ ์ธ์‚ฐํ™”๋ฅผ ์–ต์ œํ•˜์˜€์œผ๋ฉฐ Smad ์‹ ํ˜ธ์ „๋‹ฌ์ฒด๊ณ„๋„ ์–ต์ œํ•˜์˜€๋‹ค. ์ด๋กœ์ธํ•ด coptisine์ด Snail์˜ ์ƒ์œ„ ์‹ ํ˜ธ์ „๋‹ฌ์ฒด๊ณ„์— ์˜ํ–ฅ์„ ๋ฏธ์ณ Snail์˜ ๋ฐœํ˜„์„ ์ €ํ•ดํ•˜๋Š” ๊ฒƒ์„ ์•Œ ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ coptisine์˜ Snail ์–ต์ œ์™€ E-cadherin ์ฆ๊ฐ€ ์ž‘์šฉ์„ ํ†ตํ•ด EMT๊ฐ€ ํšจ๊ณผ์ ์œผ๋กœ ์ €ํ•ด๋˜๋Š” ๊ฒƒ์œผ๋กœ ์—ฌ๊ฒจ์ง„๋‹ค. ๋”ฐ๋ผ์„œ coptisine์€ ์•” ์ „์ด ์น˜๋ฃŒ์˜ ์ฒœ์—ฐ ํ›„๋ณด ๋ฌผ์งˆ์ด ๋  ์ˆ˜ ์žˆ์„ ๊ฒƒ์œผ๋กœ ์‚ฌ๋ฃŒ๋œ๋‹ค. ๊ณจ ํ•ญ์ƒ์„ฑ (bone homeostasis)์€ ํŒŒ๊ณจ์„ธํฌ (osteoblast)์˜ ๊ณจ ํก์ˆ˜ (bone resorption)์™€ ์กฐ๊ณจ์„ธํฌ (osteoblast)์˜ ๊ณจ ํ˜•์„ฑ (bone formation)์— ์˜ํ•ด ์œ ์ง€๋˜๋ฉฐ ํ•ญ์ƒ์„ฑ์ด ํŒŒ๊ดด๋  ๊ฒฝ์šฐ ๊ณจ๋‹ค๊ณต์ฆ๊ณผ ๊ฐ™์€ ๊ณจ ๊ด€๋ จ ์งˆํ™˜์ด ๋ฐœ์ƒํ•œ๋‹ค. ์กฐ๊ณจ์„ธํฌ๋Š” Wnt ์‹ ํ˜ธ์ „๋‹ฌ์ฒด๊ณ„์— ์˜ํ•ด ๋ถ„ํ™”๊ฐ€ ์ด‰์ง„๋˜์–ด extracellular matrix (ECM) ๋‹จ๋ฐฑ์งˆ์˜ ๋ฐœํ˜„๊ณผ ๋ฌด๊ธฐ์งˆํ™” (mineralization)๊ฐ€ ์ผ์–ด๋‚˜๋ฉฐ ์ด๋Ÿฌํ•œ ์ด์œ ๋กœ Wnt ์‹ ํ˜ธ์ „๋‹ฌ์ฒด๊ณ„์˜ ํ™œ์„ฑํ™”๋Š” ๊ณจ๋‹ค๊ณต์ฆ ์น˜๋ฃŒ์ œ์˜ ์ƒˆ๋กœ์šด ํ‘œ์ ์œผ๋กœ ์—ฌ๊ฒจ์ง€๊ณ  ์žˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ์ฒœ์—ฐ๋ฌผ ์ค‘ ๋ฐ”๋””๋‚˜๋ฌผ (Angelica decursiva)์—์„œ ๋ถ„๋ฆฌํ•œ furano-coumarin๊ณ„์—ด์˜ nodakenetin์ด Wnt ์‹ ํ˜ธ์ „๋‹ฌ์ฒด๊ณ„๋ฅผ ํ™œ์„ฑํ™”์‹œ์ผœ ์กฐ๊ณจ์„ธํฌ์˜ ๋ถ„ํ™”์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š”์ง€ ์‚ดํŽด๋ณด์•˜๋‹ค. Nodakenetin์€ ์ธ๊ฐ„ ์‹ ์žฅ ๋ฐฐ์•„ ์„ธํฌ์ฃผ์ธ HEK293 ์„ธํฌ์™€ ์ฅ ์ „์กฐ๊ณจ์„ธํฌ์ฃผ์ธ CM3T3-E1 ์„ธํฌ์—์„œ T-cell factor/Lymphoid-enhancing factor (TCF/Lef)์˜ ์ „์‚ฌํ™œ์„ฑ์„ ํฌ๊ฒŒ ์ฆ๊ฐ€์‹œ์ผฐ๋‹ค. Wnt ์‹ ํ˜ธ์ „๋‹ฌ์ฒด๊ณ„์˜ ์ €ํ•ด์ž์ธ Dickkopf1 (DKK1)์„ ๊ฐ์†Œ์‹œํ‚ค๊ณ  ๋ฐ˜๋Œ€๋กœ ฮฒ-catenin์€ ํฌ๊ฒŒ ์ฆ๊ฐ€์‹œ์ผฐ๋‹ค. Wnt ์‹ ํ˜ธ์ „๋‹ฌ์ฒด๊ณ„์˜ ํ‘œ์  ์œ ์ „์ž์˜ ๋ฐœํ˜„์„ ์ฆ๊ฐ€ ์‹œ์ผฐ์œผ๋ฉฐ ๊ทธ ์ค‘ ์กฐ๊ณจ์„ธํฌ ๋ถ„ํ™”์™€ ๊ด€๋ จ๋œ runt-related transcription factor2 (Runx2)์˜ ์œ ์ „์ž์™€ bone morphogenetic protein (BMP)์˜ ๋ฐœํ˜„์„ ์ฆ๊ฐ€์‹œ์ผฐ๋‹ค. MC3T3-E1 ์„ธํฌ์—์„œ Alizarin red S staining๊ณผ alkaline phosphatase (ALP) activity๋ฅผ ์ˆ˜ํ–‰ํ•œ๋ฐ”, ๋ฌด๊ธฐ์งˆํ™”๊ฐ€ ์ฆ๊ฐ€ํ•˜๊ณ , ALP๊ฐ€ ํ™œ์„ฑํ™”๋˜์–ด ์กฐ๊ณจ์„ธํฌ์˜ ๋ถ„ํ™”๋ฅผ ์ด‰์ง„ํ•˜๋Š” ๊ฒƒ์„ ํ™•์ธํ•˜์˜€๋‹ค. ๊ฒฐ๊ณผ์ ์œผ๋กœ nodakenetin์€ ์กฐ๊ณจ์„ธํฌ์˜ ๋ถ„ํ™”๋ฅผ ์ด‰์ง„ํ•˜๋Š” ๊ณจ๋‹ค๊ณต์ฆ์˜ ์น˜๋ฃŒ์— ์œ ํšจํ•œ ์„ ๋„๋ฌผ์งˆ๋กœ ์‚ฌ๋ฃŒ๋œ๋‹ค.Coptisine, an isoquinoline alkaloid, is a component of Coptis japonica Makino (Ranunculaceae). C. japonica has been used as a traditional medicine for the treatment of fungal infection and inflammation. The present study was designed to investigate the inhibitory effect of coptisne on epithelial-to-mesenchymal transition (EMT) in cancer cells. EMT is a differentiation switch in which polarized epithelial cells differentiate into contractile and motile mesenchymal cells. Coptisine showed a potential growth inhibitory activity in human lung cancer A549 cells (IC50= 8.4 ฮผM for 72 h). Coptisine increased E-cadherin promoter activity and the expressions of E-cadherin protein and mRNA level. In addition, coptisine down regulated the EMT-related protein expressions including Snail, MMP-2, vimentin, and N-cadherin. Coptisine also suppressed the expressions of phosphorylated ERK1, Akt and GSK3ฮฒ in TGFฮฒ-treated or untreated A549 cells. These results indicated that coptisine inhibited upstream signaling of Snail. Further study revealed that coptisine inhibited cell migration in the wound healing and colony dispersion assays. Cell invasion was also mediated by coptisine in the matrigel invasion assay. Coptisine might have a potential anti-metastatic activity, and thus will be a lead candidate as an anti-cancer agent. Nodakenetin, a furanocoumarin compound, is a component of Angelica decursiva (Umbelliferae). A. decursiva is used as a traditional medicine to relive the symptoms associated with allergy and skin whitening. In the present study, the effect of nodakenetin anti-osteoporosis activity was evaluated. The Wnt signaling pathway is an evolutionarily conserved pathway involved in various biological events, including stem cell differentiation, cell motility, and cell proliferation. Activation of the Wnt signaling is known to contribute to differentiation in osteoblast. Nodakenetin was found to have an activation effect ฮฒ-catenin/T-cell factor (TCF) transcriptional activity in HEK293 cells. The activation sequentially stimulated of Wnt signaling target genes and ฮฒ-catenin in both HEK293 cells and MC3T3-E1 cells. In addition, nodakenetin surppressed the expression of DKK1, a Wnt inhibitor. Nodakenetin is considered a potent Wnt activator. Nodakenetin markedly increased alkaline phosphatase (ALP) activity and extracellular matrix (ECM) calcium deposits in osteoblast cells. These data demonstrated that nodakenetin activated the Wnt signaling, which increased BMPs and Runx2 expressions, and stimulated osteoblast differentiation. Therefore, the activation of Wnt signaling by nodakenetin is considered to be associated with the anti-osteoporotic activity.์ดˆ ๋ก i ๋ชฉ ์ฐจ iv ๊ทธ ๋ฆผ ๋ชฉ ์ฐจ vii ํ‘œ ๋ชฉ ์ฐจ x Part 1. ์ฒœ์—ฐ๋ฌผ ์œ ๋ž˜ Alkaloid๊ณ„ Coptisne์˜ Epithelial-to- Mesenchymal Transition ์–ต์ œ ์—ฐ๊ตฌ 1 I. ์„œ ๋ก  2 II. ์‹คํ—˜ ์žฌ๋ฃŒ ๋ฐ ๋ฐฉ๋ฒ• 6 A. ์‹คํ—˜ ์žฌ๋ฃŒ 6 1. ์‹œ์•ฝ 6 2. ์‹œํ—˜๋ฌผ์งˆ 7 3. ์„ธํฌ ๋ฐฐ์–‘ 7 B. ์‹คํ—˜ ๋ฐฉ๋ฒ• 9 1. ์„ธํฌ ๋…์„ฑ ์‹คํ—˜ (SRB assay) 9 2. Transfection and luciferase reporter gene assay 10 3. Western blot analysis 10 4. Reverse transcription real-time PCR 11 5. Wound healing assay 13 6. Colony dispersion assay 13 7. Invasion assay 13 III. ์‹คํ—˜ ๊ฒฐ๊ณผ 16 1. Coptisine์˜ ์‚ฌ๋žŒ ํ์•” ์„ธํฌ์— ๋Œ€ํ•œ ์ฆ์‹ ์–ต์ œ ํšจ๊ณผ 16 2. E-cadherin promoter์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 18 3. EMT๊ด€๋ จ ๋‹จ๋ฐฑ์งˆ๊ณผ mRNA์˜ ๋ฐœํ˜„์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 20 4. ์„ธํฌ์˜ ์ด๋™์„ฑ์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 23 5. ์„ธํฌ์˜ ์นจ์œค์„ฑ์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 26 6. ERK์™€ Akt์˜ ์ธ์‚ฐํ™”์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 28 7. TGFฮฒ๋ฅผ ์ฒ˜๋ฆฌํ•œ A549์—์„œ ERK์™€ Akt์˜ ์ธ์‚ฐํ™”, E-cadherin๊ณผ Snail์˜ ๋ฐœํ˜„์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 30 8. TGFฮฒ๊ด€๋ จ ๋‹จ๋ฐฑ์งˆ์ธ Smad์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 32 IV. ๊ณ  ์ฐฐ 34 Part 2. ์ฒœ์—ฐ๋ฌผ ์œ ๋ž˜ Coumarin๊ณ„ Nodakenetin์˜ ์กฐ๊ณจ์„ธํฌ ๋ถ„ํ™” ์—ฐ๊ตฌ 36 I. ์„œ ๋ก  37 II. ์‹คํ—˜ ์žฌ๋ฃŒ ๋ฐ ๋ฐฉ๋ฒ• 41 A. ์‹คํ—˜ ์žฌ๋ฃŒ 41 1. ์‹œ์•ฝ 41 2. ์‹œํ—˜๋ฌผ์งˆ 42 3. ์„ธํฌ ๋ฐฐ์–‘ 42 B. ์‹คํ—˜ ๋ฐฉ๋ฒ• 44 1. ์„ธํฌ ๋…์„ฑ ์‹คํ—˜ (MTT assay) 44 2. Transfection and luciferase reporter gene assay 44 3. Western blot analysis 45 4. Reverse transcription real-time PCR 46 5. Measurement of Alkaline phosphatase (ALP) activity 47 6. Measurement of extracellular matrix (ECM) calcium deposits 47 III. ์‹คํ—˜ ๊ฒฐ๊ณผ 50 1. Nodakenetin์˜ ฮฒ-catenin/T-cell factor (TCF) transcriptional activity์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 50 2. Wnt signaling pathway์— ๊ด€๋ จ๋œ ๋‹จ๋ฐฑ์งˆ์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 53 3. ์กฐ๊ณจ์„ธํฌ์—์„œ Wnt signaling pathway์— ๊ด€๋ จ๋œ ๋‹จ๋ฐฑ์งˆ์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 56 4. ์กฐ๊ณจ์„ธํฌ ๋ถ„ํ™”์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 59 5. BMPs์™€ Runx2์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ 62 IV. ๊ณ  ์ฐฐ 64 ์ฐธ ๊ณ  ๋ฌธ ํ—Œ 66 Abstract 70Maste

    A Study on Pintings of Eight Royal Tombs and Historic Sites in Hamgyong Province in Joseon Dynasty

    No full text
    ํ•จ๊ฒฝ๋„๋Š” ๋ถ๋ฐฉ ๋ณ€๊ฒฝ์ง€๋Œ€์ด๋ฉฐ ํƒœ์กฐ ์ด์„ฑ๊ณ„์™€ ๊ทธ ์„ ์กฐ๋“ค์˜ ์œ ์ ์ด ์žˆ๋Š” ่ฑŠๆฒ›ไน‹้„•์œผ๋กœ ์ง€์นญ๋˜์—ˆ๋‹ค. ์กฐ์„ ์€ ๊ฑด๊ตญ ์งํ›„๋ถ€ํ„ฐ ์„ธ์ข…์กฐ์— ๊ฑธ์ณ ์ˆ˜์ฐจ๋ก€ ๋‘๋งŒ๊ฐ• ์ผ๋Œ€๋ฅผ ๊ณต๋žตํ•˜์—ฌ ์—ฌ์ง„์กฑ์„ ๋ชฐ์•„๋‚ด๊ณ  6์ง„์„ ์„ธ์›Œ ๊ฐ•์—ญ์„ ํ™•๋ณดํ•˜์˜€๋‹ค ์ดํ›„ ํ•จ๊ฒฝ๋„ ๊ตญ๋ฐฉ์„ ์œ„ํ•ด ๅพ™ๆฐ‘ๆ”ฟ็ญ–๊ณผ ๋™์‹œ์— ์ด ์ง€์—ญ์˜ ์œ ๋ ฅํ•œ ์„ธ๋ ฅ์„ ํšŒ์œ ํ•˜๊ณ  ํ–‰์ •์ฒด๊ณ„์— ํŽธ์ž…์‹œํ‚ค๋Š” ๅฃซๅฎ˜ๅˆถ๋ฅผ ์‹œํ–‰ํ•˜์˜€๋‹ค. 15์„ธ๊ธฐ ์ค‘์—ฝ ์ดํ›„๋Š” ๊ตญ๊ฒฝ์ด ํ™•๋ณด๋˜๊ณ  ์‚ฌํšŒ๊ฐ€ ์•ˆ์ •๋˜๋ฉด์„œ ํ•จ๊ฒฝ๋„์— ๋Œ€ํ•œ ๊ด€์‹ฌ์€ ์ ์ฐจ ์ค„์—ˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ 1712๋…„ (์ˆ™์ข… 38) ์กฐ์„ ๊ณผ ์ฒญ ์‚ฌ์ด์˜ ็™ฝ้ ญๅฑฑๅฎš็•Œ๋Š” ํ•จ๊ฒฝ๋„๋ฅผ ๋น„๋กฏํ•œ ๋ถ๋ฐฉ ์ง€์—ญ์˜ ์ธ์‹์„ ์ƒˆ๋กญ๊ฒŒ ํ•˜๋Š” ๊ณ„๊ธฐ๊ฐ€ ๋˜์—ˆ๋‹ค. ์˜์กฐ๋Œ€์—๋Š” ๊ตญ์™•์ค‘์‹ฌ์˜ ์ •์น˜์ฒด์ œ๋ฅผ ์ค‘์‹œํ•˜๋ฉด์„œ ์™•์‹ค์˜ ๊ถŒ์œ„๋ฅผ ๋†’์ด๋ ค๋Š” ์ •์ฑ…์˜ ์ผํ™˜์œผ๋กœ ์™•์‹ค์‚ฌ์  ํ˜„์ฐฝ์‚ฌ์—…์ด ์ถ”์ง„๋˜๋ฉด์„œ ํ•จ๊ฒฝ๋„ ์™•์‹ค์‚ฌ์ ์˜ ์ •๋น„๊ฐ€ ๋ณธ๊ฒฉํ™”๋œ๋‹ค. 1736๋…„(์˜์กฐ 12) ํ‘์„๋ฆฌ์— ํƒœ์กฐ ํƒ„์ƒ ๊ธฐ์ ๋น„๋ฅผ ์„ธ์šฐ์ž๋Š” ์˜ํฅ ์œ ์ƒ๋“ค์˜ ๋ฐœ์˜๋ฅผ ์‹œ์ž‘์œผ๋กœ 1747๋…„ ํ•จํฅ์ถœ์‹  ์œ„์ฐฝ์กฐ๊ฐ€ ํ•จ๊ฒฝ๋„ ์™•์‹ค ์‚ฌ์ ์„ ๋ชจ์•„ ใ€Ž๋ถ๋กœ๋Šฅ์ „์ง€ใ€๋ฅผ ํŽธ์ฐฌํ•˜์˜€๊ณ , 1758๋…„ ๊ตญ๊ฐ€ ์ฐจ์›์˜ ใ€Ž๋ถ๋„๋Šฅ์ „์ง€ใ€ ํŽธ์ฐฌ ์‚ฌ์—…์ด ์ง„ํ–‰๋˜์—ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์‚ฌ์—…์€ ์ •์กฐ๋Œ€์—๋„ ๊ทธ๋Œ€๋กœ ๊ณ„์Šน๋˜์–ด ํ‘์„๋ฆฌยท๋…์„œ๋‹นยท์น˜๋งˆ๋Œ€ ๋“ฑ์— ๊ธฐ์ ๋น„๋ฅผ ์„ธ์šฐ๊ณ , 1795๋…„ ใ€Žๆˆ่ˆˆๆœฌๅฎฎๅ„€ๅผ ยท ใ€Žๆฐธ่ˆˆๆœฌๅฎฎๅ„€ๅผใ€์„ ๊ฐ„ํ–‰ํ•˜์—ฌ ํ•จํฅ๊ณผ ์˜ํฅ์˜ ๋ณธ๊ถ์˜์‹์„ ์ •๋น„ํ•˜์˜€๋‹ค. ๋˜ํ•œ 1797๋…„ ๆก“็ฅ–์˜ ๅ…ซๅ›žๅฏถ็”ฒ(480์ฃผ๋…„)์„ ๋งž์•„ ํŽธ์ฐฌํ•œ ใ€Ž่ฑŠๆฒ›่ณ“่ˆˆ้Œ„ใ€์€ ํ•จํฅ๊ณผ ์˜ํฅ๋ณธ๊ถ์—์„œ ์ œํ–ฅ์„ ์ง€๋‚ด๊ณ  ์ทจ์žฌํ•œ ็ง‘ๆ–‡์„ ๋ชจ์•„ ์—ฎ์€ ๊ฒƒ์œผ๋กœ, ๊ตญ์™• ์ •์กฐ์˜ ์ฃผ๋„๋กœ ์กฐ์„  ๊ฑด๊ตญ ์œ„์—…๊ณผ ์™•์กฐ์˜ ์œ„์ƒ์„ ๋†’์ด๋ ค๋Š” ์˜์ง€๋ฅผ ์ž˜ ๋ณด์—ฌ์ฃผ๋Š” ์‚ฌ๋ก€์ด๋‹ค. ํ™์–‘ํ˜ธ๊ฐ€ 1799๋…„ ์ •์กฐ์—๊ฒŒ ํ•จ๊ฒฝ๋„ ์™•์‹ค์‚ฌ์ ์— ๋Œ€ํ•ด ๊ธฐ๋กํ•œ ใ€Ž่ˆˆ็Ž‹่‚‡ไน˜ใ€์„ ์˜ฌ๋ฆฐ ๊ฒƒ๋„ ์ด๋Ÿฌํ•œ ๋‹น์‹œ ๋ถ„์œ„๊ธฐ๋ฅผ ๋ฐ˜์˜ํ•œ ๊ฒƒ์ด์—ˆ๋‹ค. > ์—ญ์‹œ ํ•จ๊ฒฝ๋„์˜ ํ•จํฅ ยท ์˜ํฅ ยท ์•ˆ๋ณ€ ยท ๋ฌธ์ฒœ ๋“ฑ์— ์†Œ์žฌํ•œ ํƒœ์กฐ ๅ››ไปฃ็ฅ– ๋ฐ ๊ทธ ๅฆƒ์— ๋Œ€ํ•œ ้™ตยทๆฎฟๅฎฎ์˜ ์œ„์น˜์™€ ๊ทธ ๊ตฌ์กฐ๋ฅผ ๊ทธ๋ฆฐ ์ผ์ข…์˜ ๅœ–ๅฝข์ด๋‹ค. ๊ทœ์žฅ๊ฐ์—๋Š” ๅŒ—้“้™ตๆฎฟๅœ–ๅฝข, ์žฅ์„œ๊ฐ๊ณผ ๋ฌธํ™”์žฌ์ฒญ์—๋Š” ๅŒ—้“ๅ„้™ตๆฎฟๅœ–ๅฝข์ด๋ž€ ์ด๋ฆ„์œผ๋กœ ๊ฐ๊ฐ ํ•œ ๋ถ€์”ฉ ์†Œ์žฅ๋˜์–ด ์ด 3๋ถ€๊ฐ€ ์ „ํ•œ๋‹ค. ์ด ์ž๋ฃŒ๋Š” ํƒœ์กฐ ์ฆ‰์œ„ ์ดํ›„ ์™•์œผ๋กœ ์ถ”์กด๋œ ํƒœ์กฐ์˜ 4๋Œ€ ์กฐ์ƒ๋“ค์˜ ๋Šฅ๋ฌ˜, ์‚ฌ์  ๋ฐ ์˜›ํ„ฐ ๋“ฑ์„ ์ •๋ฆฌํ•˜์—ฌ ์กฐ์„  ์™•์กฐ์˜ ์ •ํ†ต์„ฑ ํ™•๋ฆฝ์— ํ™œ์šฉ๋˜์—ˆ์œผ๋ฉฐ, ์ดํ›„ ์กฐ์„ ์™•์‹ค ๋Šฅ๋ฌ˜ ์กฐ์„ฑ์—๋„ ์ง€์†์ ์ธ ์˜ํ–ฅ์„ ๋ฏธ์ณค๋˜ ์ ์—์„œ ์—ฐ๊ตฌ ๊ฐ€์น˜๊ฐ€ ๋†’๋‹ค. >์— ๋Œ€ํ•œ ์ œ์ž‘์‹œ๊ธฐ๋Š” ์„ ์ƒ ์—ฐ๊ตฌ๋งˆ๋‹ค ๋‹ค์†Œ ์ฐจ์ด๋ฅผ ๋ณด์ธ๋‹ค. ์ œ1์„ค์€ ๊ทœ์žฅ๊ฐ๋ณธ์˜ ์„ธ์ฃผ๋ฅผ ๊ทผ๊ฑฐ๋กœ 1755๋…„๊ฒฝ์—์„œ ์ œ์ž‘๋œ ๊ฒƒ์œผ๋กœ ์ถ”์ •ํ•˜์˜€๊ณ , ๋‚˜๋จธ์ง€ 2๋ณธ์€ ์ ์–ด๋„ 1776๋…„ ์ด์ „ ์˜์กฐ์—ฐ๊ฐ„ ๊ทธ๋ ค์ง„ ๊ฒƒ์œผ๋กœ ์ถ”์ •ํ•˜์˜€๋‹ค. ์ œ 2์„ค์€ >๊ณผ ๋™์ผํ•œ ๋‚ด์šฉ์œผ๋กœ ์ œ์ž‘๋œ ๋‚ฑ์žฅ์˜ ํ•จํฅ๋ณธ๊ถ๊ณผ ๊ฒฝํฅ์ „์„ ์ดฌ์˜ํ•œ ์œ ๋ฆฌ๊ฑดํŒ ์‚ฌ์ง„ 2์ ์˜ ์šฐ์ธก ํ•˜๋‹จ ๊ธฐ๋ก์„ ๊ทผ๊ฑฐ๋กœ 1759๋…„ 9์›” ๆดช่ฑกๆผข(1701~1769)์ด ๋ถ๋„ ์ˆœ์ฐฐ ํ›„ ์˜ฌ๋ฆฐ ๋„ํ˜•๊ณผ ๊ด€๊ณ„์žˆ์„ ๊ฒƒ์œผ๋กœ ์ถ”์ •ํ•˜์˜€๋‹ค. ์ œ3์„ค์€> ์ค‘ ์ œ12ํญ ์— ๋ณด์ด๋Š” 1716๋…„(์ˆ™์ข… 42) ๋…์„œ๋‹น ๊ธฐ์ ๋น„๋ฅผ 1797๋…„ ๋ฐ˜๋ฃก์‚ฐ ์น˜๋งˆ๋Œ€ ์˜›ํ„ฐ์— ์ •์กฐ์˜ ์–ด์ œ๋ฅผ ์ƒˆ๊ธด ์‚ฌ์ ๋น„๋กœ ๊ฐ„์ฃผํ•˜๊ณ , ๊ทธ ๋น„๊ฐ์„ ์„ธ์šด 1808๋…„์„ ์ œ์ž‘ ์—ฐ๋„์˜ ์ƒํ•œ์œผ๋กœ ๋ณด์•˜๋‹ค. ์ œ3์„ค ์ดํ›„ ๋ฏธ์ˆ ์‚ฌํ•™๊ณ„์—์„œ๋Š” 19์„ธ๊ธฐ ์ œ์ž‘์„ค์ด ์ผ๋ฐ˜ํ™”๋˜๊ณ  ์žˆ๋‹ค. ๋”ฐ๋ผ์„œ ํ•„์ž๋Š” >์— ๋ชจ์‚ฌ๋œ ์‚ฌ์ ์— ๋Œ€ํ•œ ์‚ฌ๋ฃŒ๋ฅผ ์ƒ์„ธํžˆ ๊ฒ€ํ† ํ•˜๊ธฐ ์œ„ํ•ด 1747๋…„(์˜์กฐ 23) ํ•„์‚ฌ๋œ ใ€ŽๅŒ—่ทฏ้™ตๆฎฟๅฟ—ใ€์™€ ์ด๋ฅผ 1758๋…„(์˜์กฐ 34) ์ˆ˜์ •ยท๋ณด์™„ํ•˜์—ฌ ๋ชฉํŒ๋ณธ์œผ๋กœ ๊ฐ„ํ–‰ํ•œ ใ€ŽๅŒ—้“้™ตๆฎฟ่ชŒใ€์˜ ๋‚ด์šฉ๊ณผ ๋น„๊ตยท๊ณ ์ฐฐ์„ ์„ ํ–‰ํ•  ๊ฒƒ์ด๋ฉฐ, ์ด๋ฅผ ํ† ๋Œ€๋กœ ๊ฐ ๋Šฅ์ „์˜ ์‚ฌ์  ์—ฐํ˜์„ ๋ฐํ˜€ ๊ตฌ์ฒด์ ์ธ ์ œ์ž‘ ์‹œ๊ธฐ๋ฅผ ์œ ์ถ”ํ•˜๋ ค ํ•œ๋‹ค. ๋˜ํ•œ > ํ™”๋ฉด ์œ„์˜ ๆณจ่จ˜์™€ ํ™”ํ’์„ ๋น„๊ตยท๋ถ„์„ํ•˜์—ฌ ์–‘์‹์  ํŠน์ง•์„ ์‚ดํŽด๋ด„์œผ๋กœ์จ, ์กฐ์„ ํ›„๊ธฐ ์™•์‹ค ์‚ฐ๋ฆ‰๋„์˜ ๅ…ธๅž‹์„ ์œ ์ถ”ํ•˜๋Š” ๋ฐ๋„ ์˜๋ฏธ ์žˆ๋Š” ์ž‘์—…์ด ๋  ๊ฒƒ์ด๋‹ค. ์ด๋ฅผ ์œ„ํ•ด 19์„ธ๊ธฐ ๊ทธ๋ ค์ง„ ๊ทœ์žฅ๊ฐ ์†Œ์žฅ ํ•จ๊ฒฝ๋„ ์†Œ์žฌ 8๋ฆ‰ ๊ด€๋ จ ๋„ํ˜•๊ณผ ๋น„๊ตํ•˜์—ฌ ์ƒํ˜ธ ์—ฐ๊ด€์„ฑ์€ ๋ฌผ๋ก , ํ™”ํ’ ์ƒ์˜ ์ฐจ์ด๋ฅผ ์‚ดํŽด๋ณผ ๊ฒƒ์ด๋‹ค. This study is aimed at reviewing the paintings of eight royal tombs and historic sites in Hamgyong Province in Joseon Dynasty. Bukdo Neungjeon-dohyeong (ๅŒ—้“้™ตๆฎฟๅœ–ๅฝข) painted the eight royal tombs and historic sites in Hamgyong Province are three Albums at Gyujang-gak, Jangseo-gak and Cultural Heritage Administration. After come to throne, the first king of the Joseon Dynasty, Yi Seong-gye launched to honor his eight forebears as kings and queens and to worship at national level. So the eight tombs and historic sites of Yis ancestors in Hangyong Province were regarded as a royal sanctuary. Bukdo Neungjeon-ji (ๅŒ—่ทฏ้™ตๆฎฟๅฟ—) is documentary of eight royal tombs and historic sites in Hamgyong Province in Joseon Dynasty. According to the book, King Yeongjo(r. 1724-1776) had Jo Yeong-guk (1698-1760) to paint royal historic sites in Hamgayong Province to commemorate the first King Taejos 420th birthday in 1755. Bukdo Neungjeon-dohyeong of the album at Gyujang-gak included an explanation in 1755 King Yeongjos reign on Heukseok-ri(birth town of Taejo). Two albums of Jangseo-gak and Cultural Heritage Administration copied the album of Gyujang-gak and they have delicate difference in style each other. Two albums of Jangseo-gak and Cultural Heritage Administration correspond closely in style and contents. There is not the memorial stone with inscription written by king Jeongjo(r. 1776-1800) in 1787 on Gyeongheung-jeon(a former residence of Teajo) of two albums, therefore they were painted in at least 1787. Bukdo Neungjeon-dohyeong and Bukdo Neungjeon-ji are valuable as a historical materials to secure Joseon Dynastys legitimacy and reference of another royal tombs
    • โ€ฆ
    corecore